Doctor Discussion: Inside Clinical Trials Part 1 - with Dr. Weinberg

Поділитися
Вставка
  • Опубліковано 8 вер 2024

КОМЕНТАРІ • 11

  • @edit_33
    @edit_33 Рік тому

    🎉 Exciting to see another Q&A with Dr. Weinberg! Cannot wait to learn more about clinical trials and research!

  • @Youtube_Hayatı
    @Youtube_Hayatı Рік тому

    Carbon Health sounds like a fantastic platform for integrating and conducting clinical research. Looking forward to hearing more.

  • @sedasevinc6115
    @sedasevinc6115 Рік тому

    The future of medicine needs to be diverse and inclusive, and clinical trials need to reflect that to ensure the best outcomes for everyone.

  • @G.stoneminecraft
    @G.stoneminecraft Рік тому

    Carbon Health seems to have a large presence across the U.S. and is doing some really important work in clinical research.

  • @kerembaylan8022
    @kerembaylan8022 Рік тому

    I appreciate the clear explanation of randomized and double-blinded placebo-controlled trials. It can be a mouthful, but its important to understand.

  • @ASILKURT1916
    @ASILKURT1916 Рік тому

    Its interesting to learn about the different types of trials and studies that can be conducted in clinical research.

  • @menderesgulmex1673
    @menderesgulmex1673 Рік тому

    Prospective studies are a great way to look forward in time, but its important to control for variables that could influence the results.

  • @sumeyraovus5716
    @sumeyraovus5716 Рік тому

    As someone who is interested in research, it is fascinating to think about all the steps it takes to go from concept to implementation.

  • @Cemre_solmaz_fan67
    @Cemre_solmaz_fan67 Рік тому

    Blinding both the patient and the study team is important so that theres no bias introduced into the trial.

  • @muratharmandal3019
    @muratharmandal3019 Рік тому

    Its important for patients to be able to receive the vaccine if they were part of the placebo group in a trial.

  • @galipbayram2964
    @galipbayram2964 Рік тому

    Double-blinding is important so that the investigators dont know which intervention the patient received and cannot introduce bias into the results.